The hyaluronan (HA) receptor CD44 has a well documented role in tumour metastasis. This review focuses on the potential significance of CD44 expression and function in regulating the metastasis of both haematological malignancies and solid tumours to the bone. Specifically, the review will discuss the evidence that HA-CD44 interactions facilitate the arrest of circulating malignant cells upon the bone marrow endothelial cells and discuss data that suggests CD44 may orchestrate the ability of tumour cells to regulate the modification of the bone matrix and support its colonisation by malignant cells.</p
A hallmark of all solid tumor malignancies is the ability to invade the surrounding tissue and/or me...
The aim of this current study was to examine the significance of CD44 expression in mediating cancer...
AbstractBackground: CD44 is a transmembrane receptor for the extracellular matrix glycosaminoglycan,...
The hyaluronan (HA) receptor CD44 has a well documented role in tumour metastasis. This review focus...
Osteosarcoma (OS) is the most frequent primary malignant bone cancer in children and adolescents wit...
Hyaluronan (HA), a major component of the extracellular matrix (ECM), is enriched in many types of t...
Abstract CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types inclu...
Progression to metastatic disease is the leading cause of deaths resulting from breast cancer. Under...
Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an u...
CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer s...
Metastasis is the leading cause of death in patients with cancer, and the extracellular matrix is cr...
CD44 is a cell-surface glycoprotein receptor with a well-defined HA binding domain within its amino-...
Metastasis is the predominant cause of death from cancer yet we have few biomarkers to predict patie...
Metastasis is the predominant cause of death from cancer yet we have few biomarkers to predict patie...
Breast cancer is the second most frequent cancer in middle-aged women. Control of this disease requi...
A hallmark of all solid tumor malignancies is the ability to invade the surrounding tissue and/or me...
The aim of this current study was to examine the significance of CD44 expression in mediating cancer...
AbstractBackground: CD44 is a transmembrane receptor for the extracellular matrix glycosaminoglycan,...
The hyaluronan (HA) receptor CD44 has a well documented role in tumour metastasis. This review focus...
Osteosarcoma (OS) is the most frequent primary malignant bone cancer in children and adolescents wit...
Hyaluronan (HA), a major component of the extracellular matrix (ECM), is enriched in many types of t...
Abstract CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types inclu...
Progression to metastatic disease is the leading cause of deaths resulting from breast cancer. Under...
Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an u...
CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated as a cancer s...
Metastasis is the leading cause of death in patients with cancer, and the extracellular matrix is cr...
CD44 is a cell-surface glycoprotein receptor with a well-defined HA binding domain within its amino-...
Metastasis is the predominant cause of death from cancer yet we have few biomarkers to predict patie...
Metastasis is the predominant cause of death from cancer yet we have few biomarkers to predict patie...
Breast cancer is the second most frequent cancer in middle-aged women. Control of this disease requi...
A hallmark of all solid tumor malignancies is the ability to invade the surrounding tissue and/or me...
The aim of this current study was to examine the significance of CD44 expression in mediating cancer...
AbstractBackground: CD44 is a transmembrane receptor for the extracellular matrix glycosaminoglycan,...